Pharma Stock Roundup: NVO's New Obesity Pill Data, RHHBY, AZN's Pipeline Updates
9/3 08:14
This week, data from Novo Nordisk’sNVO early-stage study on a new weight loss pill called amycretin showed that it could be more effective than its popular injection for obesity, Wegovy. The FDA approved J&J’sJNJ lung cancer m...